A major challenge for regulators is to balance the public health value of e-cigarettes against their risks, says Mitchell Zeller (Director of the Center for Tobacco Products, U.S. Food and Drug Administration).
Part of The Dr. Lawrence H. and Roberta Cohn Forums, this event was presented jointly with Reuters on May 7, 2019.
Watch the entire series:
source